Miscellaneous / Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

Forced Order
Challenge
Share
Tweet
Embed
Score 0/96 Timer 20:00
HintAnswer
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?
P-kinetics: Start with a small dose
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
Clonidine class
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
MOA: D2 receptor agonist (partial D1 agonist)
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
Use: alleviation of chorea
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
Tolcapone class
Carbamazepine class
MOA: Pure D2 receptor agonist
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
Pergolide class
Fluphenzaine class
Use: depression associated with Huntington's disease
Quetiapine class
Entacapone class
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
Bromocriptine class
Rasagiline class
Reserpine class
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
P-kinetics: Similar to Pramipexole
HintAnswer
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
MOA: Central (brain) anti-cholinergic
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
Ropinirole class
TCA class
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
Olanzapine class
Benzotropine class
Risperidone class
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
P-kinetics: Start at low dose & gradually increase
Tetrabenxine class
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
Use: Gold standard in Parkinson's dz - most efficacious treatment
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
Carbidopa + levidopa (1:10 or 1:4)
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine
Haloperidol class
Clonazepam class
Use: prolong ALS survival by months
Use: alleviation of chorea if refractory to atypical
Procyclidine class
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
Phenothiazine class
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
Pramipexole class
HintAnswer
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
Riluzole class
MOA: Preferential affinity for D3 family of receptors
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
Apomorphine class
SE: Insomnia when taken late in the day
Use: Most effective drug in tx of Tourette's
Biperiden class
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
Butyrophenones class
Amantadine class
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
MOA: D1 and D2 receptor agonist
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.
Selegiline class
Use: Similar to Pramipexole
Trihexyphenidyl class
P-kinetics: Given PO. Loses effectiveness over time.
SSRI class
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
Levodopa class
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
Orphenadrine class
Carbidopa class

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.